chrisvoncsefalvay/vaers-outcomes huggingface dataset:
TENDON EXTENDED THAT WENT DOWN FROM ARM TO ELBOW, EXTENDING ACROSS LEFT BREAST; SWOLLEN LYMPH NODES; This spontaneous report received from a consumer concerned a 59 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 01-MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 01-JUN-2021, the patient experienced tendon extended that went down from arm to elbow, extending across left breast, and swollen lymph nodes. Laboratory data (dates unspecified) included: Mammogram (NR: not provided) Abnormal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tendon extended that went down from arm to elbow, extending across left breast, and swollen lymph nodes. This report was non-serious.
Patient describe strong pain in arm making it very difficult to lift the arm for a couple of days. She also developed a rash very close to the elbow area that spread to the anterior part of the arm but not close at all to the the administration site. When she reported these adverse reactions; the pain had subsided enough for her to be able to lift her arm again  but the rash was still visible. She mentioned just using cold and hot compresses to relieve the pain and swelling.
Patient experienced bronchospasm with coughing and tongue itching approximately 10 minutes after the injection.
This case was reported by a nurse and described the occurrence of an injection site reaction in a 4 year old female pt who received DTAP (Infanrix) for prophylaxis. On 05/29/03 the pt received the 4th dose of Infanrix. On 05/29/03, at an unspecified time post-immunization, the pt experienced an injection site reaction characterized by a 10x12cm area of induration, as well as swelling, redness, and warmth. The pt was seen by the physician on 06/04/03.  The events had resolved by then, without treatment. The nurse considered the events were probably related to vaccination with Infanrix.
Information has been received from the registered nurse concerning to an approximately 6 month old patient of unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 06-JAN-2015, the patient as vaccinated with improperly stored dose of oral, ROTATEQ (lot number: J012522 with expiration date of 31-JAN-2015) (dose, route and frequency unspecified). Concomitant medications were not reported. No adverse event was reported. The outcome of the event was unknown. The causality of the events with oral, ROTATEQ was not reported. This is one of the several reports from the same reporter. Additional information has been requested.
Checking out of clinic within 10 mins of adm Hep A Hep B vaccine. Pt reports 1) funny taste in mouth, Feeling whoozy, Throat feels funny, Face became flushed.  paramedics called - responded, Splotchy red rash on face forehead), Ringing in ears, B/P 120/94, pulse reg, Once crew arrived transported to ER
devel lt arm swelling/pain/erythema c/w cellulitis;rx keflex x 10 day course;
I had sore for about a day and that is all. On 03/15/2023, I started spotting and I am post-menopausal. I contacted my doctor, and I had some test done but are unable to determine why I was spotting. As of today, the spotting has stopped.
Mild nausea/dizziness.  Monitored for 30 minutes. BP 129/77 HR 75. Released.
Long-lasting (well over 48 hours) feeling of debilitation after receiving shingles vaccine.
Super high heart rate, tingling lips, shortness of breath, rash. I went to the ER and got epinephrine
pt started w/t105 2 1/2 hrs p/vax; t102 x 3 days p/shot given;
09/16/2021-09/19/2021 Patient remained in bed coughing, feeling ill, drinking fluids and eating but slept mostly. 09/20/2021-Patient complained about being congested so she took mucus relief and cough drops 09/21/2021-09/23/2021-Patient began moving around the house feeling short of breath and a little foggy but symptoms felt to be slowly disipating and she was glad to be out of bed. Took a shower and sat outside to get fresh air and discussed how 09/16-09/19 she had never felt the burning in her chest and tightness like anything before and was glad it was over with. She was given water and left to her own accord at 10:30 pm. 09/24/21- At approximately 9:30 patient was discovered in her bed having died sometime throughout the night.
Tenderness at injection site, nothing serious; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Tenderness at injection site, nothing serious) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Tenderness at injection site, nothing serious). At the time of the report, VACCINATION SITE PAIN (Tenderness at injection site, nothing serious) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
fainted; Nausea; Headache; Slight fever; This is a spontaneous report from a contactable consumer (patient). A 22-year-old female patient receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on the left arm on 06Feb2021 17:00 at a single dose for COVID-19 immunization. Medical history included asthma. The patient's concomitant medications were not reported. The patient is not pregnant. On 07Feb2021 09:15, the patient fainted 16 hours after getting the shot. The patient also experienced nausea, headache and slight fever. The events were assessed as serious (medically significant). No treatment was received for the events. The outcome of the events was recovered on an unspecified date.  Information about batch/lot number has been requested.
My arm had a bump the size of a softball it turned red & I was in severe pain so  my mom took me to the ER.
This is an initial spontaneous report from a contactable physician through a Pfizer Company Representative. A 3-year-old patient (gender and race unknown) received a dose of PREVNAR. Relevant medical history and concomitant medications of the patient were unknown. It was reported that after vaccination the patient was diagnosed with pneumococcal disease on an unknown date. The physician was trying to find out the serotype of the pneumococcal disease by carrying out further studies on the patient. Relevant laboratory test results were unknown. Therapeutic measures taken in response to the event, if any, were unknown. At the time of the report, the clinical outcome of the event was unknown. Follow-up (08Jul2011): Follow-up attempts completed. No further information expected. Follow-up (28Sep2011): Follow-up attempts completed. No further information expected.
2 1/2 weeks after vaccine, and in the context of cold symptoms, developed progressive drowsiness and hypotonia. Initially treated with IVIG for presumptive Guillain-Barre Syndrome. No improvement. Then the working diagnosis became botulism-however, the cultures were negative. Current working diagnosis is Bickerstaff encephalitis. He did have antecedent viral symptoms, so the link to his 4 months vaccines is not solid.
Yesterday 09/26/2021 I received my second moderna dose but instead of on the deltoid muscle I received a bit higher specifically my shoulder. The pain feels 10 times planful than the first shot so I believe it was placed Incorrectly.
after first dose developed fever 101, shaking chills, anorexia, malaise, and myalgias. Lasted 2.5 days. Eye pain and pressure
Information has been received from a registered nurse concerning a female health care student in her early twenties who in 2001 was vaccinated with a first and second dose of varicella virus vaccine live. The reporter indicated that the patient now shows a negative titer. No medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Soreness in left arm for the first day (August 12th) into all of the next day (August 13th), finally ebbing on the 14th. Pronounced upper lip swelling occurred on August 16th, and pronounced lower lip swelling occurred on August 18th into the 19th. Minor nose swelling on August 23rd, treated by taking 2 Benedryl to mitigate swelling. Between these swelling incidents, I also experienced itchiness and red patches on various body parts, but especially on left wrist.
Patient states at 600 that evening her Fibromyalgia pain was intensified,vision problems in both eyes,patient states she was almost blind and patient states she was extremely tired. Patient states that she had to stay in bed due to being extremely tired Patient states that her husband contacted ER that evening and same stated that have had numerous patient having the same symptoms after the Pfizer vaccine. ER advised husband not to bring patient to the ER, all descrbed above was side effects of the vaccine. Patient received Pfizer vaccine 5-7-21 and patient states that all above symptoms lasted to yesterday 5-17-21.
The day after my second Covid shot, while just standing still and with nothing to precipitate it, had about 3 minutes of very rapid (~167) heartbeat with very strong heart movement in my chest.  My heart rate is normally in the 60's, blood pressure low, no heart or health problems, and nothing like this has ever happened before.  Within a few minutes, I felt fine and have not changed my regular exercise or anything else.
Since a few hours after receiving my 2nd does of the Pfizer vaccine, I have had a terrible taste in my mouth.  It has been over a week now and the taste does not go away.
can't smell or taste anything; can't smell or taste anything; Head cold; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), via an unspecified route of administration on 18Dec2020 at single dose for immunization. Medical history and concomitant medications were no. Patient got the Covid vaccine on 18Dec2020, towards the end of her shift around 1800 on 22Dec2020, she felt like she was getting a head cold. On 23Dec2020 morning, patient stated she cannot smell or taste anything. Outcome of all events was not recovered.   Reporter seriousness for cannot smell or taste as not serious.
Vomiting started within 2hrs after vaccination. Also became pale and lethargic about the same time. Poor appetite throughout the night. Brought to clinic 9/3/09. Sent to hospital for admission.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 69-year-old male patient received BNT162b2 (BNT162B2), in Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "chronic PVC's" (unspecified if ongoing); "vertigo" (unspecified if ongoing). Concomitant medication(s) included: VALIUM, start date: Nov2020, stop date: Jul2022; METOPROLOL, start date: Jan2015, stop date: Jul2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" (11Jul2022) and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (03Jul2022) Positive, notes: Tested positive(via home test) on 03Jul2022. for Covid-19; (11Jul2022) Negative, notes: Symptoms cleared in 4 days. Tested negative on 11Jul2022. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported LOE events
1st night: Had aches all over my body and severe chills. Could not sleep. Second day aches continued. Second night slept well no chills. Third morning back to normal. First dose 6 months ago I had no severe reaction.
Extreme muscle pain with limited arm use, headache, extreme tiredness, feeling dizzy and then fainting, loss of bowel control  resulting in messing bathroom floor, dehydration
This spontaneous report was received from a nurse refers to unspecified number of patients of unknown age. The medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of VARIVAX lot # M027886 30-JUN-2018, M027347 01-JUN-2018, M025871 24-MAY-2018. No adverse symptoms reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Reddened area to left upper arm 9x8 cm slightly puffy. Recommended Benadryl.
Patient develops post-vaccination syncope within 5 minutes of receiving vaccine and in route to the waiting area.  Loss of consciousness with snoring for less than 1 min.  Patient BP below normal threshold with normalization within 5 minutes.  Patients states last oral intake at 0630 on the date of immunization.
I did not have an adverse reaction to the vaccine but I test positive for Covid 19 on May 28 at a health care clinic. On May 25, I started feeling the systems of cold, stuffiness, congestion and coughing. I did a home test for Covid 19 on May 27 and it was positive. I am taking Paxlovid, 5 day dose. The medication is helping to tolerate the systems.
C/O not being able to focus - eyes deviating to (R) couldn't walk straight - lack of appetite for 24 hours - everything seemed to move to (R) - (L) arm pain and slight (L) neck pain.
A report has been received from a Health Professional concerning a 5 year old, Female subject, who had been receiving Nasal FLUMIST (intranasal), 0.2 Millilitres, Once/Single administration for recommended by the CDC. FLUMIST (intranasal) started on 16-Nov-2015 for recommended by the CDC. It was reported that on 16-Nov-2015, the patient jerked and a drop got into the patients eye. It looked like the FLUMIST stung her eye and she began to cry. FLUMIST (intranasal) was discontinued on 16-Nov-2015. The patient recovered from the event of STUNG HER EYE and PATIENT JERKED AND A DROP GOT INTO THE PATIENT'S EYE on 16-Nov-2015. The report was considered to be non-serious.
Organizing pneumonia, recurrent pneumonia, 20 lb weight loss, cold, no energy
Since approximately 3 weeks after my second dose, I have been in the worse pain I've ever experienced. The top half of my back, my neck, both shoulders, my entire right arm and sometimes even my hand are affected. This pain is constant and nothing I take for it helps. I have also experienced chest pains at least 3 times a week since getting my shot. I have no health insurance and I am a single mom to 3 kids so I have not seen a doctor about this.
Had a sore arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Had a sore arm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 650-005) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Cipro) and Penicillin allergy (Penicllin).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (Had a sore arm). At the time of the report, VACCINATION SITE PAIN (Had a sore arm) had resolved.            No concomitant medications was provided by the reporter. No treatment medications was provided by the reporter. It was unknown whether vaccines was given within 1 month prior to Moderna COVID-19 vaccine.  had not caused patient to seek medical care. It was unknown patient had experienced a similar event in the past.
Patient woke up with a fever of 101.2 and had a fever (up to 102.6) until 11/4/09; controlled with Ibuprofen as needed.
Pt given "vaccines" and ibuprofen on 11/20/12. Presented to ER w/ generalized rash over body.
Patient developed cellulitis rash on right arm.  Patient was taken to ER by mother and was told to just keep an eye on rash. No treatment was given in ER.
Hot skin at vacination site. Next day 08/13/2011-08/16/2011-Vaccination site was swollen and red felt hot to the touch and was painful to the touch. This went on for several days. Swelling went down and upper arm was sore to the touch for two to three days after.
low grade fever; body aches; soreness at the site; Second dose delayed because Covid; This case was reported by a consumer via call center representative and described the occurrence of low grade fever in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included covid-19 (patient was diagnosed with Covid on 30th June 2020). Previously administered products included Shingrix with an associated reaction of chest pain (1st dose received on 31st January 2020 and developed fever and swelling in arm, for tolerance refer case US2022004276).   On 3rd September 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced low grade fever, general body pain, injection site pain and social problem. On an unknown date, the outcome of the low grade fever, general body pain and injection site pain were recovered/resolved and the outcome of the social problem was unknown.   It was unknown if the reporter considered the low grade fever, general body pain and injection site pain to be related to Shingrix.     Linked case(s) involving the same patient:  US2022004276  Additional details were reported as follows: The patient received second dose of Shingrix late due to Covid 19 infection. Also, after receiving second dose, the patient experienced low grade fever, body aches and soreness at site of injection, all events were later resolved. Consent to follow up was denied.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022004276:Same patient
No adverse symptoms. Report due to age only. Patient was 17 years old at time of vaccine administration.
Symptom onset was 04/27/2022, fever 102F, cough, runny nose, congestion.
Information has been received from a health care worker concerning a female patient who was vaccinated with a dose of Gardasil vaccine (yeast). The patient developed arthritis while taking the Gardasil vaccine (yeast). Unspecified medical attention was sought. The patient was not recovered. Additional information has been requested.
Patient was given adult preparation despite age of 11yo.  Discovered when recalled for 2nd dose.  Patient and patient's guardian denied any adverse effects/events
This spontaneous report was received from a nurse practitioner referring to patient of unknown age and gender. No pertinent medical history and concurrent conditions reported. On 24-JUL-2014 patient received improperly stored MMR II [lot # J010993/ exp. date 09/06/2015], exposed to 9.7 degree for 6 hours 20 minutes, subcutaneously (dose not reported). No other concomitant therapies reported. No adverse effects reported. The outcome of the events was unknown. No PQC reported. The case has been linked with cases 1407USA012136, 1407USA014425, 1407USA014427, 1407USA014428, 1407USA014429, 1407USA014430, 1408USA000006, 1408USA000009, 1408USA000012, 1408USA000013, 1408USA000015, 1408USA000832, 1408USA000838, 1408USA000843, 1408USA000848 and 1408USA000853. Additional information has been requested.
Patient complained of tingling in left hand then all over. Patient complained of dizziness. Patient was able to walk to a cooler, quieter location. Patient appeared anxious and tearful. Patent was able to talk the whole time. Patient declined any trouble breathing.  Ice pad applied to neck. Respirations 16. BP 138/92. then 130/100. No visible rash or itching. Orange juice was drank by patient with no difficulty. Patient's mom insisted on ambulance to be called. Patient's O2 was 99% on room air when checked by EMT. Patient declined going to hospital. Patient left clinic with her mom.
I had an increase of pain in the Si joint and Glute muscle in the right sight. Decrease in ability to walk. I had to get physical Therapy. 4 sessions of physical therapy and continued therapy at home. Also accu puncture treatment. Increase in neuropathy in right foot.
Pt c/o difficulty swallowing, which worsened, began coughing. Epi given IM and pt transferred to ED
Shot may have caused me to get Shingles activated later that day or the next. Day after called my family doctor for an appointment and he examined that I had a mild case of Shingles and prescribed pills to take. Still in the start of taking pills and the Shingles seems to be staying mild. I will be done with the pills around the 1st or 2nd week of January, 2002.
information has been received from the mother of a 19 year old female with a drug hypersensitivity to unspecified antibiotics. On 21 Dec 2006, the patient was vaccinated with the first dose of HPV vaccine. There were no concomitant medications reported. On 21 Dec 2006, the patient felt like her head was going to burst, she looked pale and was possibly going to faint. The patient developed temporary blindness that lasted about two minutes. The patient sought unspecified medical attention. On 21 Dec 2006, the patient had recovered from the events, "after a few minutes". Upon internal review, the temporary blindness was considered to be an other important medical event (OMIC). Additional information has been requested.
COLOR OF THE VACCINE WAS PINK; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025 expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced color of the vaccine was pink. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of color of the vaccine is pink was not reported. This report was non-serious.
Patient reported to the Dr. with arm soreness and tightness that persisted beyond the expected timeframe.  Pain and discomfort was in and around injection site.  Patient also presented with a shingles-like rash along  her neck and shoulder on side opposite of vaccine administration.  Dr. concluded she had some sort of reaction to the flu vaccine and stated she had an infection under where her shot was administered.  Dr. prescribed course of cephalexin, which corrected patient's condition.  Patient states the issues have resolved minus some discomfort at the injection site when significant pressure is applied.
Fever of 102, severe distress sounds(unable to speak), uncomfortable, agitated, crying, congested and tiredness. Lactic acid was high.